Enforcement, Litigation, and Compliance Conference:
For the Drug, Device, Food, and Tobacco Industries

December 10–11, 2024  In-Person Event

Overview

The annual Enforcement, Litigation, and Compliance Conference brings together industry, regulators, attorneys, litigators, academics, and consultants and other stakeholders to discuss trends and issues in enforcement and compliance, the latest developments in both civil and criminal litigation, and recent cases and settlements. This year’s conference will offer an opportunity to hear from and interact with top officials from FDA, DOJ, FTC, and other government agencies. Hear from your peers about how they are staying compliance- and inspection-ready, what companies need to do to plan for and manage enforcement risk, trends in criminal and civil litigation, and government priorities for the new year.

Conference Highlights:

  • Hear about top issues, priorities, and goals for 2025 directly from ORA and FDA’s Center Compliance Directors
  • Gain practical tips and best practices on preparing for and managing enforcement and compliance risk
  • Learn about trends in government and private litigation

Register

Super early registration expires 7/31/2024

$1625

Members

$2025

Non-Members

Industry

$1325

Members

$1725

Non-Members

Government
& Association

$1125

Members

$1225

Non-Members

Public/Patient Org
& Academic

$1125

Members

$1225

Non-Members

Student

$999

Members

$1225

Non-Members

Premier

Gold

Silver

MAYA P. FLORENCE
Skadden, Arps, Slate, Meagher & Flom LLP

Kelly Bonner, Duane Morris LLP
Cathy L. Burgess, Alston & Bird LLP
Andrea Chamblee, George Washington University
John Claud, Hyman, Phelps & McNamara, PC
Aaron Danzig, Arnall Golden Gregory LLP
Lynne Ensor, Parexel International Corporation
James C. Fraser, Thompson Hine LLP
Mark Carlisle Levy, Eckert Seamans Cherin & Mellott, LLC
Perham Gorji, DLA Piper LLP (US)
Monica Groat, Latham & Watkins LLP
Steven A. Johnson, FDA Counsels
Peter V. Lindsay, Paul Hastings, LLP
Tim Lombardo, EAS Consulting Group
David Lonza, NSF International
Fred Medick, Genentech, Inc.
Anne K. Miller, Medtronic
Theodora McCormick, Epstein Becker & Green, PC
Clint Narver, U.S. DOJ
Sonia W. Nath, Cooley LLP
Suzan Onel, Kleinfeld, Kaplan & Becker, LLP
Teresa Park, Covington & Burling LLP
Shannon M. Singleton, FDA – OCC
George Toscano, Toscano Consulting Group (TCG)
Beth P. Weinman, Ropes & Gray LLP

Call for Proposals

FDLI and the Conference Planning Committee thanks those who participated in the Call for Proposals this summer. The input received from industry stakeholders helps us plan a timely program. If you submitted a proposal, you will be notified of the status of your proposal in September.